MBA, Tuck School of Business, 1992; BA, Middlebury College, 1987
Health care, biopharmaceutical industry, start-ups, entrepreneurship, product launches, strategy
Contemporary Issues in Biotechnology
Kirsten Detrick is a senior biotech executive who pursued a distinguished career with Fortune 10 biopharma organizations and who now serves as a strategic adviser for life sciences start-ups in the US and abroad. Detrick has more than 30 years of experience as an established P&L leader, a strategic marketing and sales expert, and a general manager. She has successfully commercialized and launched multiple new therapeutics and built corporate drug pipelines for global biopharma organizations including Amgen, Bristol Myers Squibb, and Takeda. Detrick’s career included eight years working in Europe as a global commercial portfolio leader and, later, as a general manager for businesses located in Eastern Europe and Austria. Detrick has particular expertise in immunology, oncology, cardiovascular and rare diseases, having led multibillion-dollar therapeutics including Enbrel, Entyvio, Plavix, and Prolia during her career. She has also served on several public and nonprofit boards of directors, including roles as both member and chairman.